Today: 7 February 2026
Subscribe

High Roller Technologies stock jumps again as ROLR adds Lines.com marketing plan to Crypto.com prediction push

High Roller Technologies stock jumps again as ROLR adds Lines.com marketing plan to Crypto.com prediction push

New York, Jan 15, 2026, 13:08 (ET) — Regular session Shares of High Roller Technologies jumped roughly 44%, hitting $27.20 in afternoon trading Thursday. The NYSE American-listed online gaming stock is continuing a volatile two-day rally. So far today, the price has swung between $19.08 and $29.05. The shift is significant as High Roller aims to expand beyond its online casino roots into U.S. prediction markets — a space where traders deal in contracts linked to event outcomes, ranging from sports scores to economic figures. Investors usually react quickly to such pivots, well before any revenue surfaces. It thrusts a
15 January 2026
····
GE Vernova stock nudges up after Jefferies lifts target to $865, with earnings next

GE Vernova stock nudges up after Jefferies lifts target to $865, with earnings next

New York, January 15, 2026, 12:58 (ET) — Regular session Shares of GE Vernova climbed $4.85, or roughly 0.8%, to $649.03 in midday trading Thursday in New York, following Jefferies’ decision to lift its price target from $830 to $865 while keeping a buy rating, MT Newswires reported. The stock hit an intraday high of $666 and a low of $647.92. (MarketScreener) The new target arrives just under two weeks before GE Vernova releases its fourth-quarter and full-year results on Jan. 28, before the market opens. Traders are moving fast to jump on—or steer clear of—any momentum building ahead of
15 January 2026
····
Texas Instruments stock slips despite chip rally as Barclays, Wells Fargo and Citi reset targets

Texas Instruments stock slips despite chip rally as Barclays, Wells Fargo and Citi reset targets

New York, Jan 15, 2026, 12:53 (EST) — Regular session Texas Instruments (TXN) shares dropped 0.8% to $191.87 by midday Thursday, while the VanEck Semiconductor ETF climbed over 3%. The divergence is significant as Wall Street recalibrates its outlook for chip sector performance in 2026. Texas Instruments, linked more to steady demand in everyday electronics than to flashy AI hardware, occupies a different niche. Several new research notes landed on Thursday, signaling a potentially volatile stretch ahead of earnings. Texas Instruments produces analog and embedded processing chips—components that control power, sense and relay data, and manage core functions—with key customers
15 January 2026
·····
Thermo Fisher (TMO) stock rises again as CEO points to U.S. reshoring contracts

Thermo Fisher (TMO) stock rises again as CEO points to U.S. reshoring contracts

New York, Jan 15, 2026, 13:00 ET — Regular session Thermo Fisher Scientific shares rose roughly 0.7% to hit $626.17 by midday Thursday, building on gains from the day before. CEO Marc Casper said Thermo Fisher’s pharmaceutical services have secured contracts to help clients move production from Europe and Asia back to the U.S. “There’s a very big focus on reshoring more production and activity to the U.S.,” he noted, calling it a tailwind for 2027 and 2028. Casper added that Thermo’s acquisition of Sanofi’s Ridgefield, New Jersey facility aims to boost capacity in support of this shift. (Reuters) Why
15 January 2026
·····
CrowdStrike (CRWD) stock rises after judge tosses outage lawsuit, Seraphic deal in focus

CrowdStrike (CRWD) stock rises after judge tosses outage lawsuit, Seraphic deal in focus

NEW YORK, Jan 15, 2026, 12:50 EST — Regular session CrowdStrike Holdings Inc (CRWD.O) shares rose on Thursday after a U.S. judge dismissed a shareholder fraud lawsuit tied to the company’s July 2024 software outage. The stock was up 1.2% at $466.07 in midday trading, after closing at $460.70 in the prior session. (Investing.com) The ruling trims a legal overhang that has sat on the stock since the outage, when investors were already jittery about software quality controls at one of the market’s highest-profile cybersecurity vendors. It also lands in the middle of a broader debate about whether security budgets
15 January 2026
·····
Shopify stock ticks higher after Toronto tech rout as AI-shopping push stays in view

Shopify stock ticks higher after Toronto tech rout as AI-shopping push stays in view

New York, Jan 15, 2026, 12:45 PM ET — Regular session Shares of Shopify Inc climbed roughly 0.8% to $158.7 on Thursday, bucking a volatile market following a selloff in Canadian tech stocks the day before. This matters because Shopify now acts as a high-beta barometer for risk appetite in software and online retail. When investors pull back from growth due to geopolitics or interest rates, the stock usually reacts quickly. Wall Street found some footing Thursday, with tech and major indexes edging higher despite new U.S. data muddying the outlook for near-term rate cuts. (Reuters) On Wednesday in Canada,
15 January 2026
·····
Netflix stock ticks up as Delaware judge blocks Paramount fast-track in Warner deal fight

Netflix stock ticks up as Delaware judge blocks Paramount fast-track in Warner deal fight

New York, Jan 15, 2026, 12:16 EST — Regular session Shares of Netflix (NFLX.O) ticked up 0.6% to $89.08 midday Thursday, as investors digested a Delaware court decision related to its planned buyout of Warner Bros Discovery’s studios and streaming units. The ruling keeps the takeover battle alive, leaving timing and price uncertain. Traders are watching the stock closely, viewing it as a gauge of whether Netflix can pull off a game-changing deal without stumbling over politics, financing, or regulatory hurdles. Next Tuesday brings Netflix’s quarterly results, adding pressure to an already busy week. The Warner process looms large, casting
15 January 2026
······
Pfizer stock dips as U.S. vaccine policy fight rattles demand outlook

Pfizer stock dips as U.S. vaccine policy fight rattles demand outlook

New York, Jan 15, 2026, 11:16 EST — Regular session. Pfizer Inc. shares fell 0.6% to $25.42 in late-morning trading on Thursday, extending a choppy start to the year for the drugmaker’s stock. The stock has struggled to find a clear driver since Pfizer warned in December that 2026 would likely start “bumpy,” with lower COVID-related sales, price cuts tied to a U.S. government deal and key patent expirations looming. Loss of exclusivity is shorthand for patents ending, which can open the door to cheaper rivals. (Reuters) The political noise around vaccines is back in focus. Sanofi Chief Executive Paul
15 January 2026
·········
Capital One stock rises as traders weigh US credit-card rate cap risk ahead of earnings

Capital One stock rises as traders weigh US credit-card rate cap risk ahead of earnings

New York, Jan 15, 2026, 12:31 PM ET — Trading in the regular session. Shares of Capital One Financial Corp climbed Thursday, building on a recovery after earlier declines as investors reconsidered the policy risks tied to U.S. credit-card pricing. The stock gained 2.2%, reaching $239.55 by midday trading. The lender is at the heart of the debate about whether Washington can — or will — push down credit-card interest rates. For shareholders, the implications are clear: lower rates could slash interest income, prompting lenders to tighten credit, cut rewards, or hike fees. That debate is running headlong into earnings
15 January 2026
····
Adobe stock slips again as Oppenheimer downgrade and Apple’s Creator Studio keep pressure on ADBE

Adobe stock slips again as Oppenheimer downgrade and Apple’s Creator Studio keep pressure on ADBE

New York, January 15, 2026, 12:42 EST — Regular session Adobe Inc shares edged down 0.6% to $302.49 on Thursday midday, even as the Invesco QQQ Trust tracking the Nasdaq 100 rose about 1%. Salesforce slid more than 3%, while the S&P 500 ETF SPY added about 0.6%. The slide comes two days after Oppenheimer cut Adobe to “Perform” from “Outperform,” warning that generative AI — tools that can create images and video from text prompts — is tightening competition from OpenAI, Meta and others. “Gen AI is increasing the velocity of content creation while lowering price and subscriber growth,”
15 January 2026
······
Accenture stock steadies near $289 as Wells Fargo raises target; traders eye March 19 earnings call

Accenture stock steadies near $289 as Wells Fargo raises target; traders eye March 19 earnings call

New York, Jan 15, 2026, 12:24 EST — Regular session Accenture plc shares (ACN) were up about 0.1% at $288.87 on Thursday, holding most of Wednesday’s 4.2% jump. The stock closed the prior session at $288.54. (MarketWatch) The move matters because investors are trying to pin down whether corporate tech budgets are finally thawing, after a year of stop-start spending on big projects. For Accenture, bookings and discretionary work are the tell, not the chatter. Analyst notes are landing in a market that wants evidence, fast. Any hint that CIOs are reopening wallets can move the group, even if the
15 January 2026
·····
AST SpaceMobile stock flirts with $100 as Zacks’ “Bear of the Day” clashes with satellite bulls

AST SpaceMobile stock flirts with $100 as Zacks’ “Bear of the Day” clashes with satellite bulls

New York, Jan 15, 2026, 11:56 EST Shares of AST SpaceMobile climbed roughly 4% Thursday, hovering near $99 amid sharply divided opinions on the satellite-to-smartphone firm’s valuation and execution risks. The tug-of-war is crucial now as “direct-to-device” connectivity—satellites linking regular smartphones without cell towers—shifts from demos to early commercial rollout. This shift has pushed what was once a niche telecom gamble into the spotlight for retail investors and telecom executives alike. AST plans to roll out 45 to 60 satellites in 2026, a milestone its supporters believe could transform coverage in rural and remote regions. Skeptics, however, warn this ambitious
15 January 2026
·····
1 … 623 624 625 626 627 … 2,711

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Go toTop